Table 2.
Main ongoing clinical trials exploring the role of olive oil compounds in the prevention and treatment of cancer patients.
| Name of Study and NCT Number | Phase | Study Arms | N° of Patients | Study Type | Status |
|---|---|---|---|---|---|
| Phase 3 Study of Enteral Nutrition Rich in Eicosapentaenoic Acid (EPA) in Patients Receiving Chemotherapy for Gastric Cancer or Colorectal Cancer NCT01048463 [27] |
Phase 3 | Placebo Comparator: EN vs. Experimental: ENLDEPA (Nutriall+LDEPA+ Xelox) vs. Experimental: ENHDEPA (nutriall+HDEPA+ Xelox) | 90 | Interventional | Unknown status |
| A Mediterranean Diet in Colon Cancer Prevention NCT00475722 [28] |
Not Applicable | Active Comparator: 1 Healthy Eating vs. Experimental: 2 Mediterranean | 120 | Interventional | Completed |
| The Effects of EPA on Biomarkers of Growth and Vascularity in Human Colorectal Cancer Liver Metastases (The EPA for Metastasis Trial) NCT01070355 [29] |
Phase 2 | Placebo Comparator: Placebo vs Active. Comparator: EPA free fatty acid | 88 | Interventional | Completed |
Abbreviations: EN: enteral nutrition; EPA: Eicosapentaenoic Acid; vs.: versus; N°: number.